Article Source: Trudeau signs deal to make abortion-tainted COVID vaccines in Canada | News | LifeSite
Big Tech is censoring us. Subscribe to our email list and bookmark LifeSiteNews.com to continue getting our news. Subscribe now.
OTTAWA, Canada, February 3, 2021 (LifeSiteNews) — Canada has announced a deal with pharmaceutical giant Novavax, allowing the company to manufacture its COVID-19 vaccine in Montreal. Speaking to the press on February 2, Canadian Prime Minister Justin Trudeau also revealed that another deal had been signed with Precision NanoSystems.
Trudea signed a “memorandum of understanding” with Novavax, giving them permission to manufacture their vaccine at the National Research Council Royalmount site in Montreal, which is still under construction.
Trudeau predicted that Novavax would be able to produce “2 million doses of vaccine per month” at the site, which would help him to deliver on his promise to vaccinate “every Canadian who wants a vaccine.” Novavax’s arrival would most likely not be until later in 2021.
In addition to this, Vancouver-based Precision NanoSystems has been awarded “a federal investment of $25 million,” assisting it not only to build a manufacturing center for COVID vaccines, but to be able to produce “up to 240 million doses” by the time the center is completed in 2023.
During his press statement, Trudeau also highlighted the investment of $46 million in the vaccine…